DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
clinicaltrials.gov.
Atezolizumab, Pertuzumab and Trastuzumab With Chemotherapy as Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer (APTneo). NIH U.S. National Library of Medicine, 2020.
Accessed November 17, 2020 at:
https://clinicaltrials.gov/ct2/show/NCT03595592
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.